Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Pilot Phase II Research Study of EF5 to Measure Tumor Hypoxia in Patients With Non-Small Cell Lung Cancer

NCT00041028 is registered in ClinicalTrials.gov with Duke University as lead sponsor.

NCT NCT00041028
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00041028 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Pilot Phase II Research Study of EF5 to Measure Tumor Hypoxia in Patients With Non-Small Cell Lung Cancer
Lead sponsor
Duke University
Phase
Phase 2
Overall status
Completed
Start date
May 31, 2002
Completion date
April 30, 2014
Enrollment
60 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

lung cancer